Literature DB >> 29933768

Canine Prostate Disease.

Bruce W Christensen1.   

Abstract

All intact, male dogs will experience benign prostatic hyperplasia and hypertrophy, usually by around 6 years old. Although these dogs will be predisposed to prostatic infections, only a small subset will actually develop infections or show clinical signs of discomfort or subfertility. Neutered male dogs have a higher incidence of neoplasia associated with the prostate. Updated diagnostic tests, including canine prostate-specific arginine esterase, are discussed. Castration is compared with medical treatment options. Updated treatment recommendations include reducing antibiotic exposure to 4 weeks for bacterial infections and use of nonsteroidal antiinflammatory drugs for neoplastic disease.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Benign prostatic hyperplasia (BPH); Canine prostate-specific arginine esterase (CPSE); Prostate; Prostatic neoplasia; Prostatitis

Mesh:

Year:  2018        PMID: 29933768     DOI: 10.1016/j.cvsm.2018.02.012

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  7 in total

1.  A retrospective review of canine benign prostatic hyperplasia with and without prostatitis.

Authors:  Hannah Ruetten; Marlyse Wehber; Mary Murphy; Clara Cole; Simran Sandhu; Steven Oakes; Dale Bjorling; Kenneth Waller; Katrina Viviano; Chad Vezina
Journal:  Clin Theriogenology       Date:  2021-12

2.  Does finasteride treatment for benign prostatic hyperplasia influence sperm DNA integrity in dogs?

Authors:  Daniel S R Angrimani; Luana C Bicudo; Nuria Llamas Luceño; Bruno R Rui; Matheus F Silva; João D A Losano; Bart Leemans; Ann Van Soom; Camila I Vannucchi
Journal:  Basic Clin Androl       Date:  2020-07-16

Review 3.  Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions.

Authors:  Eduardo de Paula Nascente; Renée Laufer Amorim; Carlos Eduardo Fonseca-Alves; Veridiana Maria Brianezi Dignani de Moura
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

4.  An immunohistochemical prostate cell identification key indicates that aging shifts procollagen 1A1 production from myofibroblasts to fibroblasts in dogs prone to prostate-related urinary dysfunction.

Authors:  Hannah Ruetten; Clara Cole; Marlyse Wehber; Kyle A Wegner; Nicholas M Girardi; Nelson T Peterson; Brandon R Scharpf; Michael F Romero; Michael W Wood; Sara A Colopy; Dale E Bjorling; Chad M Vezina
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240

5.  Transcriptome of Two Canine Prostate Cancer Cells Treated With Toceranib Phosphate Reveals Distinct Antitumor Profiles Associated With the PDGFR Pathway.

Authors:  Priscila E Kobayashi; Patrícia F Lainetti; Antonio F Leis-Filho; Flávia K Delella; Marcio Carvalho; Sarah Santiloni Cury; Robson Francisco Carvalho; Carlos E Fonseca-Alves; Renée Laufer-Amorim
Journal:  Front Vet Sci       Date:  2020-11-26

Review 6.  Comparative pathology of dog and human prostate cancer.

Authors:  Toby Ryman-Tubb; Jennifer H Lothion-Roy; Veronika M Metzler; Anna E Harris; Brian D Robinson; Albert A Rizvanov; Jennie N Jeyapalan; Victoria H James; Gary England; Catrin S Rutland; Jenny L Persson; Lukas Kenner; Mark A Rubin; Nigel P Mongan; Simone de Brot
Journal:  Vet Med Sci       Date:  2021-10-10

7.  Total Perineal Prostatectomy: A Retrospective Study in Six Dogs.

Authors:  Daniele Zambelli; Giulia Ballotta; Simona Valentini; Marco Cunto
Journal:  Animals (Basel)       Date:  2022-01-14       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.